Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework

Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework

The emergence and spread of multidrug-resistant tuberculosis (MDR-TB), i.e. involving resistance to at least isoniazid and rifampicin, could threaten the control of TB globally. Controversy has emerged about the best way of confronting MDR-TB in settings with very limited resources. In 1999, the Wor...

Full description

Bibliographic Details
Main Authors: Pablos-Méndez Ariel, Gowda Deepthiman K., Frieden Thomas R.
Format: Article
Language:English
Published: The World Health Organization 2002-01-01
Series:Bulletin of the World Health Organization
Subjects:
Tuberculosis, Multidrug-resistant/drug therapy
Tuberculosis, Multidrug-resistant/epidemiology
Tuberculosis, Multidrug-resistant/history
Antitubercular agents/therapeutic use
Antitubercular agents/economics
Treatment outcome
Developing countries
Online Access:http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862002000600015

Internet

http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0042-96862002000600015

Similar Items